USING BASE-LINE MEASUREMENTS IN THE 2-PERIOD CROSSOVER CLINICAL-TRIAL

被引：20

作者：

WILLAN, AR ^{[1
]}

PATER, JL ^{[1
]}

机构：

[1] QUEENS UNIV,DEPT COMMUNITY HLTH,KINGSTON K7L 3N6,ONTARIO,CANADA

来源：

CONTROLLED CLINICAL TRIALS | 1986年 / 7卷 / 04期

关键词：

D O I：

10.1016/0197-2456(86)90036-X

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：282 / 289

页数：8

共 11 条

[1] CROSSOVER EXPERIMENT FOR CLINICAL-TRIALS [J].

BROWN, BW .

BIOMETRICS, 1980, 36 (01) :69-79

[2]

Cox DR., 1958, PLANNING EXPT

[3] PLASMAPHERESIS THERAPY IN RHEUMATOID-ARTHRITIS - A CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL [J].

DWOSH, IL ;

GILES, AR ;

FORD, PM ;

PATER, JL ;

ANASTASSIADES, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (19) :1124-1129

[4] ADJUSTING FOR BASELINE MEASUREMENTS IN THE 2-PERIOD CROSSOVER STUDY - A CAUTIONARY NOTE [J].

FLEISS, JL ;

WALLENSTEIN, S ;

ROSENFELD, R .

CONTROLLED CLINICAL TRIALS, 1985, 6 (03) :192-197

[5]

GRIZZLE JE, 1965, BIOMETRICS, V21, P469

[6]

GRIZZLE JE, 1974, BIOMETRICS, V30, P727

[7] 2-PERIOD CROSSOVER CLINICAL-TRIAL [J].

HILLS, M ;

ARMITAGE, P .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) :7-20

[8] INTRODUCTION TO SAMPLE-SIZE DETERMINATION AND POWER ANALYSIS FOR CLINICAL-TRIALS [J].

LACHIN, JM .

CONTROLLED CLINICAL TRIALS, 1981, 2 (02) :93-113

[9] CROSSOVER AND SELF-CONTROLLED DESIGNS IN CLINICAL RESEARCH [J].

LOUIS, TA ;

LAVORI, PW ;

BAILAR, JC ;

POLANSKY, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (01) :24-31

[10] VALIDITY OF CROSSOVER TRIALS [J].

VERE, DW .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) :5-6

← 1 2 →